A program 100% dedicated to translational research on diabetes
Organised by the Lund University Diabetes Center, Eurasanté and the NHL Cluster, and supported by Ascenion, AstraZeneca, Novo Nordisk and Sanofi, the IDEA Summit is a unique European event entirely dedicated to collaborative research and technology transfer in the field of diabetes. The aim of this meeting is to be a platform for dialogue and strengthen links between academia and industry. We hope that exchanges and discussions at this event will stimulate collaborative research for the prevention, diagnosis and treatment of diabetes and its complications.
At IDEA Summit’s previous editions, it became clear that academia and industry made progress in understanding each other’s strengths and driving forces. However, there is still a great need to continue to develop new ways to stimulate interaction and more effective knowledge and resources sharing, and even go further and involve patients by creating sustainable links between academics and clinicians.
The different panels will provide a framework of wider discussions on bottlenecks that contribute to slow translation of diabetes research and on what can be done to bridge the existing gaps. Moreover, the partnering will give the opportunity to engage new collaborating opportunities and dialogues among the actors in this field.
IDEA Summit’s 4th edition will offer on 30th November: A conference programme dedicated to shed the light on recent innovations and clinical achievements in the field of diabetes and on 1st December: A one-to-one partnering session provided by BioFIT enabling pharma, biotech, diagnostics companies, research institutes, academia, TTOs and investors to explore licensing & collaborative opportunities.
To register for IDEA Summit 2016, please contact Margaux SATOLA – firstname.lastname@example.org / +33 (0) 359 390 182